ArticleEmerging infectious diseases2025
Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023-2024.
Article in Emerging infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Safety and durability of influenza and SARS-CoV-2 antibody responses through 6 months after a single dose of mRNA-1083, a multicomponent influenza and COVID-19 vaccine, in adults ≥50 years.Human vaccines & immunotherapeutics · 2026Trial
- Remote Monitoring Approaches to Reduce Readmissions After Infection and Sepsis: A Randomized Clinical Trial.JAMA network open · 2026Trial
- Temporal Alignment of Wastewater Signals with Clinical Indicators of Respiratory Illness Postpandemic, Texas, USA.Emerging infectious diseases · 2026Article
- A subunit vaccine for multiple respiratory viruses.Science advances · 2026Article
- Trends in incidence and DALYs of infectious disease from 2000 to 2023 and the attributable risk factors in China: an analysis of the Global Burden of Disease Study 2023.The Lancet regional health. Western Pacific · 2026Article
- Differences in healthcare resource utilization by race/ethnicity among moderate to late preterm infants with respiratory distress Syndrome, Northern California.Journal of perinatology : official journal of the California Perinatal Association · 2026Article
- Statewide Transfer Coordination and Patient Transfer Rates Among Hospitals During Occupancy Stress.JAMA network open · 2025Article
- Estimated impact of 2022-2023 influenza vaccines on annual hospital burden in the United States.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- Improving outbreak forecasts through model augmentation.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Projections for the US 2023-24 respiratory virus season indicated a 31% decrease to a 55% increase in hospitalizations for respiratory syncytial virus, influenza, and COVID-19 compared with 2022-23, depending on circulating variants and vaccination uptake. The projections captured the tripledemic peak but missed the multiwave seasonality of COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.